Editas Medicine

Editas Medicine is a leading biotechnology company focused on developing transformative gene-editing therapies to treat a range of serious diseases. They leverage CRISPR technology to create precise genomic modifications, aiming to correct genetic defects at their source. Founded in 2013, Editas has made significant strides in the field, including pioneering work on therapies for genetic eye disorders and blood diseases. Their revenue model primarily revolves around research and development collaborations, licensing agreements, and potential future product sales as their therapies advance through clinical trials.

Recent Posts by Editas Medicine

1-20 of 30